Pasithea Therapeutics Corp. (KTTAW) Gross Profit (2022)

Pasithea Therapeutics has disclosed Gross Profit across 1 years of filings, most recently posting $242020.0 for Q4 2022.

• In Q4 2022, Gross Profit changed N/A year-over-year to $242020.0; the TTM figure through Dec 2022 stood at $373364.0 (changed N/A YoY), while the FY2022 annual figure was $373364.0, up 16971.4% from the prior year.
• Gross Profit came in at $242020.0 for Q4 2022 at Pasithea Therapeutics, up from $132143.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $242020.0 in Q4 2022 to a low of -$1520.0 in Q2 2022.